Search earnings tickers

TMO

2026Q1BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2026-04-23 · Fiscal end 2026-03-31 · Features as of 2026-04-22

← Earnings history

Street

Consensus EPS5.24

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.9%

IV front—

P/C full—

P/C front—

Features as of2026-04-22

Run-up

Close—

Ret 5d-3.3%

Ret 10d+2.1%

Ret 20d+4.8%

Ret 30d+2.8%

Print

Actual EPS

5.44Beat

Estimated EPS5.24

Actual revenue

11.0B

Surprise %+3.8%

Beat / missBeat

Beat streak 44

Beat streak 88

Reaction

1-day stock reaction-1.3%

Implied vs actual

Implied 1.9%Actual 8.0%

Gap reaction-8.0%

Day result-9.2%

Next-day upNo

Realized / IV4.20×

Post tape

Post 5d+2.6%

Post 10d+1.7%

Post volume5.7M

Vol ×10d3.19×

Vol ×20d3.35×

Post range4.4%

TMO

Pre-Earnings Data